Skip to content
Recall Observatory FDA recall evidence

Drug product

Leukine sargramostim 5 x 500 mcg/mL vial, liquid injection, Sterile Rx only, Mfd by: Bayer HealthCare Pharmaceuticals, LLC Seattle, WA 98101 U.S. Lic. No. 1791 NDC 58468-0181-2

D-156-2013

May 31, 2012

Class III

Product summary

Firm
Bayer HealthCare Pharmaceuticals Inc.
Event
Event 62908
Status
Terminated
Classification
Class III
Quantity
138,505 vials
Official record key
drug-enforcement:D-156-2013

Official wording

Reason: Impurities/Degradation Products: A confirmed out of specification result for Leukine sargramostin lot B18827 occurred at the three month time point.

Code information: B18511 Exp. 04/12 , B18513 Exp. 05/12, B18515 Exp. 06/12, B18517 Exp. 06/12, B18825 Exp. 10/12, B18831 Exp.12/12

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification